Arvinas Inc (ARVN)
32.66
+0.55
(+1.71%)
USD |
NASDAQ |
May 17, 16:00
31.01
-1.65
(-5.05%)
Pre-Market: 20:00
Arvinas Total Return Level: 32.68 for May 17, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
May 17, 2024 | 32.68 |
May 16, 2024 | 32.11 |
May 15, 2024 | 32.33 |
May 14, 2024 | 31.36 |
May 13, 2024 | 31.57 |
May 10, 2024 | 31.44 |
May 09, 2024 | 31.95 |
May 08, 2024 | 32.37 |
May 07, 2024 | 34.33 |
May 06, 2024 | 32.26 |
May 03, 2024 | 32.82 |
May 02, 2024 | 32.43 |
May 01, 2024 | 32.48 |
April 30, 2024 | 31.77 |
April 29, 2024 | 31.90 |
April 26, 2024 | 32.37 |
April 25, 2024 | 31.60 |
April 24, 2024 | 32.54 |
April 23, 2024 | 34.00 |
April 22, 2024 | 34.90 |
April 19, 2024 | 34.72 |
April 18, 2024 | 34.29 |
April 17, 2024 | 33.45 |
April 16, 2024 | 33.44 |
April 15, 2024 | 34.72 |
Date | Value |
---|---|
April 12, 2024 | 36.29 |
April 11, 2024 | 37.26 |
April 10, 2024 | 36.73 |
April 09, 2024 | 38.08 |
April 08, 2024 | 37.65 |
April 05, 2024 | 37.44 |
April 04, 2024 | 37.90 |
April 03, 2024 | 38.59 |
April 02, 2024 | 39.04 |
April 01, 2024 | 40.40 |
March 28, 2024 | 41.28 |
March 27, 2024 | 41.33 |
March 26, 2024 | 41.00 |
March 25, 2024 | 40.67 |
March 22, 2024 | 41.90 |
March 21, 2024 | 43.35 |
March 20, 2024 | 44.16 |
March 19, 2024 | 42.56 |
March 18, 2024 | 42.60 |
March 15, 2024 | 44.85 |
March 14, 2024 | 44.72 |
March 13, 2024 | 46.48 |
March 12, 2024 | 45.48 |
March 11, 2024 | 45.50 |
March 08, 2024 | 47.04 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
14.19
Minimum
Oct 27 2023
107.87
Maximum
Jul 29 2021
45.38
Average
40.67
Median
Mar 25 2024
Total Return Level Benchmarks
Pfizer Inc | 99.34 |
Johnson & Johnson | 496.58 |
Bristol-Myers Squibb Co | 176.18 |
Janux Therapeutics Inc | 47.10 |
ACADIA Pharmaceuticals Inc | 14.79 |